Songyu Tian
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Retraction: MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
Journal: Oncotarget
Published: April 24, 2026
Comprehensive molecular characterization of hypertension-related genes in cancer.
Journal: Cardio-oncology (London, England)
Published: February 09, 2022
Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation.
Journal: Neuroscience
Published: August 02, 2021
Therapeutic Targeting of Tumor Cells Rich in LGR Stem Cell Receptors.
Journal: Bioconjugate chemistry
Published: January 25, 2021
PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients.
Journal: Frontiers in cell and developmental biology
Published: October 16, 2020
The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis.
Journal: Journal of cellular and molecular medicine
Published: January 19, 2020
Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.
Journal: Journal of cellular and molecular medicine
Published: June 02, 2019
Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: August 18, 2017
Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Journal: Pathology, research and practice
Published: April 08, 2017
Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain.
Journal: Molecular medicine reports
Published: October 01, 2016
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
Journal: Oncotarget
Published: July 25, 2016
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Journal: Anesthesia and analgesia
Published: January 01, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026